UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis

Gut, 2010-01, Vol.59 (1), p.49-54

2010

Volltextzugriff (PDF)

The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (10), p.1329-1338

2017

Volltextzugriff (PDF)

Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2010-01, Vol.31 (1), p.20-34

2010

Volltextzugriff (PDF)

Editorial: is it time for therapeutic drug monitoring of anti‐TNF agents during pregnancy? Maybe, maybe not. Author's reply

Alimentary pharmacology & therapeutics, 2017-06, Vol.45 (12), p.1556-1557

Seow, C. H.

2017

Volltextzugriff (PDF)

Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases

Alimentary pharmacology & therapeutics, 2017-12, Vol.46 (11-12), p.1037-1053

2017

Volltextzugriff (PDF)

Management of Inflammatory Bowel Disease in Pregnancy: A Practical Approach to New Guidelines

Canadian journal of gastroenterology & hepatology, 2016-01, Vol.2016, p.9513742-4

2016

Volltextzugriff (PDF)

Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (9), p.1232-1243

2017

Volltextzugriff (PDF)

Editorial: different tests for different drugs in Crohn’s disease, or different tests for different people?

Alimentary pharmacology & therapeutics, 2017-08, Vol.46 (4), p.463-464

2017

Volltextzugriff (PDF)

Editorial: vedolizumab in pregnancy – is gut selectivity as good for baby as it is for mum?

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (9), p.1283-1284

2017

Volltextzugriff (PDF)

Towards Routine Non-invasive Monitoring of Disease Activity Using Gastrointestinal Ultrasound and Faecal Calprotectin in Pregnant Women With IBD

Journal of Crohn's and colitis, 2020-12, Vol.14 (12), p.1790-1791

2020

Volltextzugriff (PDF)

Traditional corticosteroids for induction of remission in Crohn's disease

Cochrane database of systematic reviews, 2008-04 (2), p.CD006792

2008

Volltextzugriff (PDF)

Reduction in surgical stoma rates in Crohn's disease: a population‐based time trend analysis

Colorectal disease, 2019-11, Vol.21 (11), p.1279-1287

2019

Volltextzugriff (PDF)

Commentary: detection of infliximab levels and anti‐infliximab antibodies

Alimentary pharmacology & therapeutics, 2013-01, Vol.37 (1), p.153-154

2013

Volltextzugriff (PDF)

P372 Barriers and facilitators of the transition from paediatric to adult care in inflammatory bowel disease: A Western Canadian perspective

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i786-i786

2024

Volltextzugriff (PDF)

P481 "I’ve been told to drop out of school because I need to focus on my health and that was just devastating to hear.": Experiences of Western Canadian young adults with inflammatory bowel disease transitioning from paediatric to adult care

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i964-i965

2024

Volltextzugriff (PDF)

Oral budesonide for induction of remission in ulcerative colitis

Cochrane database of systematic reviews, 2010-10 (10), p.CD007698

2010

Volltextzugriff (PDF)

P511 Association of ustekinumab serum concentrations and clinical outcomes: results from the mUST-DECIDE trial

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S443-S444

2020

Volltextzugriff (PDF)

Budesonide for maintenance of remission in Crohn's disease

Cochrane database of systematic reviews, 2009-01 (1), p.CD002913

2009

Volltextzugriff (PDF)

Budesonide for induction of remission in Crohn's disease

Cochrane database of systematic reviews, 2008-01 (3), p.CD000296

2008

Volltextzugriff (PDF)

Point of Care Ultrasound Accurately Distinguishes Inflammatory from Non Inflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S644-S645

2017

Volltextzugriff (PDF)

Capsule endoscopy in the detection of small-intestinal bleeding in patients supported by a nonpulsatile axial-flow Jarvik 2000 left ventricular assist device

Gastrointestinal endoscopy, 2006-06, Vol.63 (7), p.1087-1087

Seow, Cynthia

2006

Volltextzugriff (PDF)

Budesonide for Crohn's disease

Expert opinion on drug metabolism & toxicology, 2009-08, Vol.5 (8), p.971-979

2009

Volltextzugriff (PDF)

Managing the risks of IBD therapy

Current gastroenterology reports, 2009-12, Vol.11 (6), p.509-517

2009

Volltextzugriff (PDF)

Colectomy is a risk factor for venous thromboembolism in ulcerative colitis

World journal of gastroenterology : WJG, 2015-01, Vol.21 (4), p.1251-1260

2015

Volltextzugriff (PDF)

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

Gastroenterology (New York, N.Y. 1943), 2016-03, Vol.150 (3), p.734-757.e1

2016

Volltextzugriff (PDF)

1 – 25 von 514

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(481)
Mit Volltextzugriff
(464)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis

The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease

Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease

Editorial: is it time for therapeutic drug monitoring of anti‐TNF agents during pregnancy? Maybe, maybe not. Author's reply

Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases

Management of Inflammatory Bowel Disease in Pregnancy: A Practical Approach to New Guidelines

Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort

Editorial: different tests for different drugs in Crohn’s disease, or different tests for different people?

Editorial: vedolizumab in pregnancy – is gut selectivity as good for baby as it is for mum?

Towards Routine Non-invasive Monitoring of Disease Activity Using Gastrointestinal Ultrasound and Faecal Calprotectin in Pregnant Women With IBD

Traditional corticosteroids for induction of remission in Crohn's disease

Reduction in surgical stoma rates in Crohn's disease: a population‐based time trend analysis

Commentary: detection of infliximab levels and anti‐infliximab antibodies

P372 Barriers and facilitators of the transition from paediatric to adult care in inflammatory bowel disease: A Western Canadian perspective

P481 "I’ve been told to drop out of school because I need to focus on my health and that was just devastating to hear.": Experiences of Western Canadian young adults with inflammatory bowel disease transitioning from paediatric to adult care

Oral budesonide for induction of remission in ulcerative colitis

P511 Association of ustekinumab serum concentrations and clinical outcomes: results from the mUST-DECIDE trial

Budesonide for maintenance of remission in Crohn's disease

Budesonide for induction of remission in Crohn's disease

Point of Care Ultrasound Accurately Distinguishes Inflammatory from Non Inflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea

Capsule endoscopy in the detection of small-intestinal bleeding in patients supported by a nonpulsatile axial-flow Jarvik 2000 left ventricular assist device

Budesonide for Crohn's disease

Managing the risks of IBD therapy

Colectomy is a risk factor for venous thromboembolism in ulcerative colitis

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

Suchergebnisse filtern